Moe, M., Micallef, R., Pwint, T., Maughan, T., Mort, D., & Wagstaff, J. (2008). Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer.
Style de citation Chicago (17e éd.)Moe, M., R. Micallef, T. Pwint, T. Maughan, D. Mort, et J. Wagstaff. Cetuximab Plus Irinotecan as Third Line Chemotherapy for Metastatic Colorectal Cancer. 2008.
Style de citation MLA (9e éd.)Moe, M., et al. Cetuximab Plus Irinotecan as Third Line Chemotherapy for Metastatic Colorectal Cancer. 2008.
Attention : ces citations peuvent ne pas être correctes à 100%.